RT Journal Article
SR Electronic
T1 Capturing noroviruses circulating in the population: sewage surveillance in Guangdong, China (2013-2018)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.20.20173088
DO 10.1101/2020.08.20.20173088
A1 Lu, J.
A1 Fang, L.
A1 Peng, J.J.
A1 Zeng, L.L.
A1 Lin, H.F.
A1 Xiong, Q.L.
A1 Yi, L.N.
A1 Song, T.
A1 He, J.F.
A1 Sun, L. M.
A1 Ke, C.W.
A1 Li, H.
A1 Zheng, H.Y.
YR 2020
UL http://medrxiv.org/content/early/2020/08/22/2020.08.20.20173088.abstract
AB Noroviruses (NoVs) are the leading cause of acute gastroenteritis outbreaks. The specific geographical distribution and expanding diversity of NoVs has posed a challenge to NoV surveillance and interventions. Here, we describe the long-term dynamic correlation between NoV distribution in sewage and in the local population by using high-throughput sequencing and operational taxonomic unit (OTU) analysis. The NoV viral loads in sewage were closely associated with the number of NoV outbreaks in the population. Compared with the viral distributions in outbreaks, the dominance of the newly emerged variants, such as GII.P17-GII.17 and GII.P16-GII.2, could be detected two months ahead in sewage. In addition, the dynamics of pre-epidemic variants, which were rarely detected from clinics, could be captured through sewage surveillance, thus improving our understanding of the viral origin and evolution. Our data highlight that the high-throughput environmental screening should become a critical part of the response to infectious diseases.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialthis is not clinical trail studyFunding StatementThis study was supported by The Key Research and Development Program of Guangdong Province (2019B111103001), Science and Technology Planning Project of Guangzhou (201804010030) and China Evergrande Group (2020GIRHHMS11)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All epidemiological data were acheived from Guangdong Proviical norovirus surveillance system. The study has been approved by ethics committee of the Center for Disease Control and Prevention of Guangdong Province.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll sequencing data have been submitted to public database.